Strand Life Sciences

Explore our tests

20 Years of Genomics Experience

We spun off from the Indian Institute of Science. We created the first College of American Pathologists-accredited laboratory for Genomic Sequencing in India. We have contributed to ~25000 peer-reviewed scientific publications that push the frontiers of genomics research. The bioinformatics platforms and the medical literature curation capabilities that power our tests are tried and tested, not only by us but by many leading global genomics companies

Experience Image

Oncology Treatment Selection

There are ~55 genomic biomarkers that influence Standard of Care therapeutic decision-making. In addition, there are ~120 genomic biomarkers that influence therapy choice on an experimental basis. Our tests cover all the above, both from tissue and from liquid biopsies. Our reporting is driven by decade long investment in curating medical literature per the Association of Molecular Pathology Guidelines. Here is a publication showing the extensive validation our tests goes through.

speciality_icon

Breast Cancer

speciality_icon

Ovarian Cancer

speciality_icon

Lung Cancer

speciality_icon

Colon Cancer

speciality_icon

Prostate Cancer

speciality_icon

Endometrial Cancer

speciality_icon

All Cancers

Cancer Risk

~10% of all breast and ovarian cancers globally and a fraction of colorectal, prostate and pancreatic cancers occur on account of inherited mutations. Our pioneering publication shows this fraction is at least as high if not substantially higher in India.

Read more...
Comprehensive Gene Coverage

Comprehensive Gene Coverage

Our test covers all genes clinically proven to carry inherited risk for Breast, Ovarian, Prostate, Pancreatic, Colorectal and Hematological cancers

Detailed Variant Analysis

Detailed Variant Analysis

We carefully handle all the variant complexity: confounding base calls, pseudogenes, copy number variants etc

Accurate Variant Classification

Accurate Variant Classification

Our variant classifications per the American College of Medical Pathologist guidelines are based on a decade of investment in automation and medical literature curation

Rare Diseases and Reproductive Health

Our Exome and Low Pass Whole Genome tests along with supporting Sanger/MLPA tests provide a comprehensive solution to the diagnosis of ~5000 Mendelian diseases. Our tests ensure accurate calling of Single Nucleotide Variants, Insertions, and Deletions, as well as Multi-exon and some single-exon Deletions & Duplications to achieve industry-leading diagnostic rates.

In a cohort of >1000 Pediatric Neurology cases, 12% of the variants called by our test were copy number variants that are otherwise hard to identify (see publication)

Read more...
Rare Diseases and Reproductive Health
disease__icon

Our Exome provides >100x coverage on >95% of the bases in genes associated with ~5000 mendelian disorders

disease__icon

Our bioinformatics platforms carry more than a decade of investment in the latest algorithms and curation of medical literature, and are used globally

disease__icon

Our team of over 50 bioinformaticians and medical genetics specialists reviews each variant carefully to handle the many complex issues that can stand between the right diagnosis and a wrong one

GenomicWellness

For healthy adults who are curious about their genomes: get your genome sequenced and keep in touch with the scientific progress that is happening at a breakneck pace to manage any genomic risks to your health.

Genomic Health Insights

For those who are curious about their genome: get your genes sequenced and keep in touch with scientific progress that can help manage any genomic risks to your health. We will sequence all ~20,000 genes and you will receive your results on a secure portal comprising risk reports for various diseases, carrier status for mutations that might affect your children, as well as genetic predispositions to commonly used drugs.

Know more
Genomic Health Insights

Breast Assure - Strand's HBOC Test

Hereditary Breast and Ovarian Cancer syndrome (HBOC) is a genetic condition that makes it more likely that a person will get breast, ovarian, and other cancers.

HBOC is hereditary, meaning that it is caused by a mutation (genetic change) that can be passed down in families. A genetic test can help determine if your personal or family history of cancer was caused by HBOC. If you are found to have HBOC, there are interventions that can help prevent cancer or detect it early.

Know more
Breast Assure - Strand's HBOC Test

Bioinformatics & Variant Interpretation

Genome sequencing on a single sample yields 10-100 Gigabytes of data; it’s easy to miss the important bits unless ones analytical platforms are robust and thorough. Our proprietary platforms below have been built entirely from scratch and have matured over a decade of clinical use.

Strand NGS

Strand NGS processes GBs of data automatically to convert raw sequencing output to genomics variants. Over 800 global publications and industry leading visualization attest to its robustness

Strand Omics

With streamlined workflows, powerful filtering, extensive curated content, and detailed audit logs, Strand Omics enables reliable identification of the one or two key genomic variants from the tens to hundreds of thousands found for each sample in inherited diseases cases.

Strand Iris

With its extensive database of 30,000 variants in 600 genes, ~750 drug associations, 80,000 clinical trials and an extensive rules engine, Strand Iris enables robust and automated identification of appropriate cancer treatment

Covid-19 Genomic Surveillance

Strand is part of the INSACOG consortium and worked closely with philanthrophic partners and the Bangalore municipality to monitor the evolution of SARS-CoV-2 strains in and around Bangalore.

Strand Testing Process

Pre-test session

with certified Genetic Counsellor where relevant

1

Sample Collection

(Blood, Saliva, Tissue Block)

2

Logistics

Pan-India coverage with 24-72 hours shipping

3

Lab Processing

Sample Preparation & Sequencing

4

Bioinformatics

Variant Interpretation

5

Reports Signout

Dispatched by email or accessed secure portal

6

Post-test session

with certified Genetic Counsellor where relevant

7

Trusted by Global Companies

Partners__icon
Partners__icon
Partners__icon
Partners__icon
Partners__icon
Partners__icon
Partners__icon
Partners__icon
Partners__icon
Partners__icon

What Our Customers Say

“Our child Sireesha had shown signs of developmental delay and poor intake of food from birth. Clinical diagnosis and confirmatory genetic testing revealed a case of Cornelia de Lange Syndrome (CdLS). Genetic testing and counseling has helped us better understand her condition for future treatment.”

Sireesha’s Parents *

“I got a 360 degree view of my cancer profile using the StrandAdvantage 152-gene test, helping me understand my treatment better and be at peace with the probabilities.”

Ila Jindal, 53 *

“Given that we had lost two of our precious children to muscular dystrophy, we wanted to ensure that the current pregnancy would be safe. The Strand test gave us confidence to go ahead with this pregnancy. We are now blessed with a healthy child!”

Radhika and Sundar *

“Genetic testing revealed certain mutations in my genome which could be targeted with precise drugs to eliminate the cancer with minimal side effects.”

Humaira, 57 *

View All

Event

Media

Publications

View All

tab__image

18 January, 2024

Personalized & Meaningful Genomics...

Join our webinar – ‘Personalized & Meaningful Genomics: A Genetic ...

tab__image

17 December, 2023

HBOC Beyond BRCA...

Join us for an insightful discussion on “HBOC Beyond BRCA: The Clinical Util...

tab__image

25 November, 2023

Role of Liquid Biopsy in NSCLC...

4th Strand Connect International Panel Discussion on Role of Liquid Biopsy in NSCL...

tab__image

24 November, 2023

Carrier Screening: Science, Economics or Comm...

Learn about the SEC’s of Carrier Screening! (S cience, E conomics, and C ommerce)<...

Strand Articles

View All

15 December, 2023

Cardiovascular Diseases in India: A Silent Genetic Threat

Sanjna Banerjee

14 December, 2023

Unmasking Silent Threats: Genetic Mutations and Sudden Cardiac Events

Sanjna Banerjee

09 November, 2023

Genetic Testing: Your Personalized Path to Wellness

Sanjna Banerjee

03 April, 2023

Why is Genomics Key to the Future of Preventive Healthcare?

Dr Ramesh Hariharan

Interested in a Career with us?

Clinician

Patient